VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ:GENT) (the “Company”) today reported that its lead investigational product, Defibrotide, will be the subject of 10 presentations and three publications at the American Society of Hematology’s (ASH) 48th Annual Meeting and Exposition being held at the Orange County Conference Center in Orlando, Florida, December 9-12, 2006.
